169 related articles for article (PubMed ID: 23028957)
1. Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy.
Shi Y; Felley-Bosco E; Marti TM; Stahel RA
PLoS One; 2012; 7(9):e45354. PubMed ID: 23028957
[TBL] [Abstract][Full Text] [Related]
2. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin protects keratinocytes from DNA damage-related pro-apoptotic stress responses stimulated by anticancer therapeutics.
Ziegler V; Albers A; Fritz G
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1082-92. PubMed ID: 26876155
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells.
Agarwal B; Bhendwal S; Halmos B; Moss SF; Ramey WG; Holt PR
Clin Cancer Res; 1999 Aug; 5(8):2223-9. PubMed ID: 10473109
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
6. Lovastatin prevents cisplatin-induced activation of pro-apoptotic DNA damage response (DDR) of renal tubular epithelial cells.
Krüger K; Ziegler V; Hartmann C; Henninger C; Thomale J; Schupp N; Fritz G
Toxicol Appl Pharmacol; 2016 Feb; 292():103-14. PubMed ID: 26739623
[TBL] [Abstract][Full Text] [Related]
7. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
Pavan S; Olivero M; Corà D; Di Renzo MF
Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
[TBL] [Abstract][Full Text] [Related]
8. An oxovanadium(IV) complex protects murine bone marrow cells against cisplatin-induced myelotoxicity and DNA damage.
Basu A; Bhattacharjee A; Samanta A; Bhattacharya S
Drug Chem Toxicol; 2017 Jul; 40(3):359-367. PubMed ID: 27868436
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
[TBL] [Abstract][Full Text] [Related]
10. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
Nilsson S; Huelsenbeck J; Fritz G
Cancer Lett; 2011 May; 304(1):60-9. PubMed ID: 21356574
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines.
Gambi N; Tramontano F; Quesada P
Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580
[TBL] [Abstract][Full Text] [Related]
12. Phyllanthus emblica Linn. fruit extract potentiates the anticancer efficacy of mitomycin C and cisplatin and reduces their genotoxicity to normal cells in vitro.
Guo XH; Ni J; Xue JL; Wang X
J Zhejiang Univ Sci B; 2017 Dec.; 18(12):1031-1045. PubMed ID: 29204983
[TBL] [Abstract][Full Text] [Related]
13. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.
Zhong WB; Hsu SP; Ho PY; Liang YC; Chang TC; Lee WS
Biochem Pharmacol; 2011 Dec; 82(11):1663-72. PubMed ID: 21907187
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
Zhong WB; Wang CY; Chang TC; Lee WS
Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
[TBL] [Abstract][Full Text] [Related]
15. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
16. Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.
Xia Z; Tan MM; Wong WW; Dimitroulakos J; Minden MD; Penn LZ
Leukemia; 2001 Sep; 15(9):1398-407. PubMed ID: 11516100
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: cisplatin and mitomycin C in cultured Vero cells.
Rjiba-Touati K; Ayed-Boussema I; Soualeh N; Achour A; Bacha H; Abid S
Exp Biol Med (Maywood); 2013 Aug; 238(8):943-50. PubMed ID: 23970409
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks.
Nübel T; Damrot J; Roos WP; Kaina B; Fritz G
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):933-9. PubMed ID: 16467108
[TBL] [Abstract][Full Text] [Related]
20. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
